DR. FORBES DENNISON PORTER, M.D.
Medical Practice in Bethesda, MD
License number
Maryland D0045118
Category
Medical Practice
Type
Clinical Genetics (M.D.)
License number
Maryland D0045118
Category
Medical Practice
Type
Pediatrics
Address
Address
10 Center Dr 10-Crc ROOM 5-2571, Bethesda, MD 20892
Phone
(301) 435-4432
Personal information
See more information about FORBES DENNISON PORTER at radaris.comName
Address
Phone
10013 Banner Country Ct, Gaithersburg, MD 20882
18604 Calypso Pl, Gaithersburg, MD 20879
Professional information
See more information about FORBES DENNISON PORTER at trustoria.com
Dr. Forbes D Porter, Bethesda MD - MD (Doctor of Medicine)
Dr. Forbes D Porter, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Pediatrics, Clinical Genetics
Address:
VALID FOR US CIVIL SERVICE EMPLOYEE ON
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
10 Ctr Dr, Bethesda 20892
(301) 435-4432 (Phone)
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
10 Ctr Dr, Bethesda 20892
(301) 435-4432 (Phone)
Certifications:
Clinical Genetics, 1996, Pediatrics, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Washington Center / School of Medicine
Graduated: 1989
Washington Center / School of Medicine
Graduated: 1989
Forbes Dennison Porter, Bethesda MD
Forbes Dennison Porter, Bethesda MD
Specialties:
Pediatrician
Address:
10 Center Dr, Bethesda, MD 20892
Board certifications:
American Board of Medical Genetics Certification in Clinical Genetics (MD) (Medical Genetics), American Board of Pediatrics Certification in Pediatrics
Substrate Reduction Therapy
Substrate Reduction Therapy
US Patent:
2014008, Mar 20, 2014
Filed:
Sep 13, 2013
Appl. No.:
14/026957
Inventors:
- Oxford, GB
Forbes Dennison Porter - Bethesda MD, US
Forbes Dennison Porter - Bethesda MD, US
Assignee:
The Chancellor, Masters and Scholars of the University of Oxford - Oxford
The Government of the United States of America, as represented by the Secretary, Department of Healt - Bethesda MD
The Government of the United States of America, as represented by the Secretary, Department of Healt - Bethesda MD
International Classification:
C07J 43/00, C07J 7/00, C07H 19/06, C07D 473/16, A61K 31/708, A61K 31/6615, A61K 31/661, A61K 31/675, C07H 19/20, A61K 31/7072, C07D 211/94, A61K 31/575
US Classification:
514 24, 51421201, 514178, 514146, 514176, 514 50, 514 25, 5142634, 514 44 R, 514171, 514170, 514 75, 514 93, 514 48
Abstract:
The present invention provides a compound which is an inhibitor of sphingolipid biosynthesis for use in the treatment of a disease which has a secondary Niemann-Pick type C disease like cellular phenotype.
Substrate Reduction Therapy
Substrate Reduction Therapy
US Patent:
8557844, Oct 15, 2013
Filed:
Jun 26, 2008
Appl. No.:
12/666279
Inventors:
Frances Mary Platt - Oxford, GB
Emyr Lloyd-Evans - Oxford, GB
Forbes Dennison Porter - Bethesda MD, US
Emyr Lloyd-Evans - Oxford, GB
Forbes Dennison Porter - Bethesda MD, US
Assignee:
The Chancellor, Masters and Scholars of the University of Oxford - Oxford
The United States of America, as represented by the Secretary, Department of Health and Human Services - Washington DC
The United States of America, as represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
A61K 31/445, A61K 31/706
US Classification:
514315, 514 27
Abstract:
The present invention provides a compound which is an inhibitor of sphingolipid biosynthesis for use in the treatment of a disease which has a secondary Niemann-Pick type C disease like cellular phenotype.